Navitrux Injection, Powder, Lyophilized, For Solution
Product Images NDC 83831-153

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Navitrux (NDC 83831-153). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avyxa Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (9cb1a2a0 B0ae 4825 A67a 31c42ef69edd 01)

Image (9cb1a2a0 B0ae 4825 A67a 31c42ef69edd 01)
Chemical structure of fosaprepitant, the active ingredient in NAVITRUX 150 mg/5 mL injection, powder, lyophilized, for solution. The image shows the molecular structure including functional groups and atoms as depicted in the product labeling.*
FDA Label Image
Navitrux (fosaprepitant) For Injection, 150 mg/vial (Carton Label)
NAVITRUX 150 mg per vial (fosaprepitant) for Injection carton label. This is a lyophilized powder for intravenous infusion after reconstitution and dilution. The label includes dosing information, storage instructions, and a warning against use with solutions containing divalent cations. It is manufactured for Avyxa Pharma, LLC and displays the NDC 83831-153-01 with barcode and a company logo.*
FDA Label Image
Navitrux (fosaprepitant) For Injection, 150 mg/vial (Container Label)
Label for NAVITRUX (fosaprepitant) Injection, 150 mg per vial. This lyophilized powder for solution is intended for intravenous infusion after reconstitution and dilution, packaged as a single-dose vial. Manufactured for Avyxa Pharma, LLC, New Jersey, USA, with storage instructions and prescribing information noted on the label.*
FDA Label Image

Image (9cb1a2a0 B0ae 4825 A67a 31c42ef69edd 140 2)

FDA Label Image

Image (Ce45271c 40ab 4ce2 B399 198cfb1253a5 136 1)

Image (Ce45271c 40ab 4ce2 B399 198cfb1253a5 136 1)
NAVITRUX 150 mg/5 mL injection, powder, lyophilized for solution is labeled for intravenous use. The packaging shows the brand name NAVITRUX prominently along with fosaprepitant as the active ingredient. The labeler is AVYXA Pharma, LLC. The design includes the company logo in blue and green and the NDC number 83831-153 is visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.